Kava to help smokers quit tobacco and cope with stress and poor sleep
Tests kava in smokers who plan to quit, looking at quitting, stress and sleep.
Key facts
- Who runs it
- University of Florida
- Where
- Gainesville, United StatesSee the site
- Trial code
- Registry title
- The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 76 people, planned
- Started
- 6 Jun 2024
- Expected to end
- 31 Oct 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Placebo
- AB-free kava
- Record updated
- 27 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who smoke and want to quit. It tests whether daily kava helps people stop smoking, lowers stress and improves sleep.
- Age
- 21 to 75 years
- Sex
- All sexes
- Disease stage
- Smoking at least 5 cigarettes a day for the past year, with the intention to quit. Breath carbon monoxide level of more than 8 ppm.
- Earlier treatment
- Not currently in any stop-smoking program. People taking kava supplements need a 2-week break before starting. People from an earlier kava trial can join after the 2-week break.
- Biomarker or test result
- Breath carbon monoxide level of more than 8 ppm. Liver blood tests (alanine transaminase, aspartate transaminase, alkaline phosphatase, total bilirubin) must not be above the normal limit.
Main reasons for not taking part
- Active cancer in the past 2 years, except non-melanoma skin cancer
- Liver problems now or in the past
- Unable to avoid acetaminophen, more than one alcoholic drink a day, or other substances that can harm the liver
- Pregnant, breastfeeding, planning pregnancy, or unwilling to use birth control
- Answering yes to suicide screening questions 1 to 3, or refusing to answer
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- adults aged 21 years or above (legal age for smoking in the U.S.) up to 75 years old
- self-reported smoking at least 5 cigarettes/day for the past year with INTENTION to quit at time of screening visit
- expired carbon monoxide level of more than 8 ppm at recruitment
- willingness to participate in the proposed study, as indicated by signed informed consent
- access to a functional telephone
- expected presence in the study's geographical area for the next 4 months
- not currently enrolled in any smoking cessation programs per self report; and
- female subjects of childbearing potential will be required to practice acceptable methods of birth control (the acceptable methods of birth control include birth control pills, Birth Control Shot, Birth Control Implant, IUD, Diaphragm, and cervical cap)
- if a participant takes kava dietary supplement, a 2-week washout period is needed for the participant to initiate this study or if a participant participated in a kava trial before, such as the kava JEK trial, the participant could be enrolled if the inclusion criteria above are met, including the 2-week washout period
Who cannot take part
- diagnosed with liver dysfunction or with previous liver diseases
- history of active cancer (other than non-melanoma skin cancer) within the past 2 years
- levels of alanine transaminase, aspartate transaminase, alkaline phosphatase or total bilirubin over limit of normal (ULN) range at prescreen
- are pregnant or nursing (lactating) or of childbearing age planning to become pregnant or unwilling to use adequate contraception during the study
- inability to refrain from acetaminophen, alcohol (no more than one drink daily via self-report), or other potentially hepatotoxic substances
- participant answered "Yes" to any of the Modified Ask Suicide Screening Questions questions 1 through 3, or refuses to answer all of the questions. If subject answers 'Yes' to question 4 but the most recent suicide attempt took place >12 months from screening visit then subject is still eligible
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 75 years old?
Where in United States
- University of FloridaGainesville, United StatesContact: Melissa MalhamTaking people
About the trial
What the trial wants to find out
This study will evaluate the compliance with a daily kava regimen among active smokers who have an intention to quit smoking. This study will also investigate whether kava use can facilitate tobacco cessation, reduce stress, and improve sleep.
The 2 groups in the trial
- AB-free kavaTreatment being tested
- Placebo controlPlacebo, for comparison
Treatment: Placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
- Plain-language title
- Kava to help smokers quit tobacco and cope with stress and poor sleepGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05814055, who can take part
- Publications
- The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and insomnia: study protocol for a randomized clinical trial.BMC complementary medicine and therapies, 2024
- Record updated
- 27 January 2026